Welcome to our dedicated page for ReposiTrak SEC filings (Ticker: TRAK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for ReposiTrak, Inc. (NYSE: TRAK), a Nevada corporation that operates a cloud-based food traceability, compliance and supply chain data platform. Through these filings, investors can review how the company reports its financial results, corporate actions and governance matters in accordance with SEC requirements.
ReposiTrak’s recent Form 8-K filings include disclosures about quarterly cash dividend declarations on its common stock, authorization of a 10b5-1 share repurchase program under a broader repurchase authorization, earnings releases for fiscal quarters and years, and the results of its annual meeting of stockholders. These current reports also reference attached press releases and earnings call transcripts that provide additional detail on financial performance, capital allocation and operational commentary.
In addition to current reports, ReposiTrak files periodic reports such as Form 10-K annual reports and Form 10-Q quarterly reports, which contain audited or reviewed financial statements, management’s discussion and analysis, risk factor disclosures and information on its business, including its focus on food traceability, regulatory compliance and supply chain solutions delivered through cloud-based applications.
Stock Titan’s filings page is designed to surface these documents as they are made available on EDGAR and to pair them with AI-powered summaries that explain the key points in accessible language. Users can quickly identify items such as dividend announcements, share repurchase authorizations, earnings results and shareholder meeting outcomes, and then drill into the underlying SEC reports for more detail. This same interface can also be used to monitor insider and executive transactions reported on forms such as Form 4, as those become available for ReposiTrak insiders.
ReposiTrak, Inc. reported that CEO, director and 10% owner Randall K. Fields sold 7,500 shares of common stock on 12/16/2025 at a weighted average price of $13.2977, coded as an "S" sale transaction.
The sale occurred automatically under a Rule 10b5-1 trading plan adopted by Fields in his capacity as trustee of the 2022 RK Fields Charitable Remainder Unitrust, the managing member of RK Fields Charitable 2022, LLC, and was established to help meet some of his charitable commitments.
After this transaction, Fields beneficially owned 3,483,955 shares of common stock directly, 175,000 shares of common stock indirectly through RK Fields Charitable 2022, LLC, 615,260 common and 229,262 Series B preferred shares through Riverview Financial Corp, 30,667 common and 5,320 Series B preferred shares through his spouse, and 333,643 common shares through Fields Management, Inc.
ReposiTrak, Inc. chairman and chief executive officer Randall K. Fields, who is also a director and 10% owner, reported a series of automatic sales of ReposiTrak common stock made by RK Fields Charitable 2022, LLC under a pre-arranged Rule 10b5-1 trading plan.
The LLC sold 4,453 shares on 12/03/2025 at a weighted average price of $13.4023, 3,000 shares on 12/08/2025 at $13.7212, 2,500 shares on 12/09/2025 at $13.6363, and 2,000 shares on 12/10/2025 at $13.6991, all coded as open-market sales. The prices reflect multiple trades within disclosed price ranges on each day.
Following these transactions, RK Fields Charitable 2022, LLC held 182,500 shares of ReposiTrak common stock. Fields also reported additional holdings, including 3,483,955 shares of common stock held directly and various indirect positions through entities such as Riverview Financial Corp., his spouse, and Fields Management, Inc., as well as related preferred stock holdings.
ReposiTrak, Inc. announced that its Board of Directors has approved a new Rule 10b5-1 share repurchase program authorizing the company to buy back up to $2 million of its common stock. This automated plan operates under the company’s previously approved overall share repurchase authorization of up to $21 million, of which $7.6 million remained available to repurchase as of December 1, 2025. The update was disclosed in a current report and accompanied by a press release filed as an exhibit.
ReposiTrak, Inc.’s chief executive officer, director and 10% owner Randall K. Fields reported small open-market sales of the company’s common stock. On 12/01/2025, an affiliated entity, RK Fields Charitable 2022, LLC, sold 2,000 shares at a weighted average price of $13.3836. On 12/02/2025, the same entity sold 1,047 shares at a weighted average price of $13.0045. Both transactions occurred under a pre-arranged Rule 10b5-1 trading plan designed to help Fields meet charitable commitments through the 2022 RK Fields Charitable Remainder Unitrust. After these sales, he reports indirect ownership of 194,453 shares through RK Fields Charitable 2022, LLC, along with additional direct and indirect holdings through other entities and his spouse.
ReposiTrak, Inc. (TRAK) CEO and 10% owner Randall K. Fields reported multiple stock movements involving company shares. On 11/24/2025, 200,000 shares of common stock were transferred out of his direct ownership and 200,000 shares were received by RK Fields Charitable 2022, LLC as a gift at a reported price of $0. The same day, that charitable entity sold 1,000 shares at a weighted average price of $13.1169, followed by an additional sale of 6,500 shares on 11/25/2025 at a weighted average price of $13.1791.
The sales were executed automatically under a Rule 10b5-1 trading plan established to help meet charitable commitments. Following these transactions, Fields reported continued indirect holdings through several entities, including RK Fields Charitable 2022, LLC, Riverview Financial Corp., his spouse, and Fields Management, Inc., as well as direct ownership of ReposiTrak common stock.
ReposiTrak, Inc. (TRAK) insider Randall K. Fields, who is a director, 10% owner and chief executive officer, reported automatic sales of common stock by an affiliated charitable entity. On 11/17/2025, 11/19/2025, and 11/20/2025, RK Fields Charitable 2022, LLC sold 1,000, 4,500 and 2,000 shares of ReposiTrak common stock, respectively, at weighted average prices of $14.807, $14.0109 and $13.4659. The filing states these transactions were executed under a pre-established Rule 10b5-1 trading plan designed to help Fields meet charitable commitments. Following these trades, Fields continues to report significant holdings, including 3,683,955 shares of common stock held directly, plus additional common and Series B preferred shares held indirectly through entities and a spouse.
ReposiTrak, Inc. reported the results of its Annual Meeting of Stockholders held on November 19, 2025. Stockholders elected four directors — Randall K. Fields, Robert W. Allen, Ronald C. Hodge and Peter J. Larkin — each by a plurality of votes cast, with support of more than 9.4 million votes for each nominee.
Stockholders also approved, on a non-binding advisory basis, the executive compensation program, with approximately 9.4 million votes cast in favor versus smaller amounts against or abstaining. In a separate advisory vote on how often to hold future say-on-pay votes, the largest number of votes, about 7.3 million, supported holding the vote every three years, and the Board determined that frequency going forward.
Additionally, stockholders ratified the appointment of Haynie & Company as the Company’s independent registered public accounting firm. These outcomes confirm continuity in the Company’s board composition, executive pay approach, and audit arrangements.
ReposiTrak, Inc. reported that it has released its financial results for the fiscal quarter ended September 30, 2025. The company issued a press release and held an earnings call on November 13, 2025 to discuss these results. The press release and the full earnings call transcript are provided as exhibits to this report, giving investors access to detailed quarterly performance information and management’s commentary. The common stock of ReposiTrak continues to trade on the New York Stock Exchange under the symbol TRAK.
ReposiTrak, Inc. (TRAK) reported Q1 FY2026 results. Revenue was $5,971,467, up 10% year over year, driven by recurring subscription and support services of $5,941,467. Net income was $1,819,529, and diluted EPS was $0.09. Income from operations reached $1,893,873.
Cash and cash equivalents were $28,794,806, with deferred revenue of $2,686,197 and no bank debt. Operating cash flow was $1,538,447. The company redeemed 70,093 shares of Series B Preferred for $749,995 and repurchased 8,715 common shares for $149,985. A quarterly cash dividend of $0.02 per share was declared. As of November 13, 2025, 18,288,455 common shares were outstanding.
Management highlights growth across compliance, supply chain, and traceability offerings as industry mandates expand. Total stockholders’ equity increased to $50,169,744.
ReposiTrak, Inc. (TRAK): CEO, director and 10% owner Randall K. Fields reported two open‑market sales under a Rule 10b5‑1 plan. On 11/10/2025, the RK Fields Charitable 2022, LLC sold 1,600 shares at a weighted average price of $15.0326. On 11/11/2025, it sold 5,900 shares at a weighted average price of $15.0248.
Following these transactions, the charitable LLC held 12,500 shares indirectly. Additional reported holdings include 3,683,955 shares directly; 615,260 shares indirectly by Riverview Financial Corp.; 333,643 shares indirectly by Fields Management, Inc.; 30,667 shares indirectly by spouse; and Series B Preferred holdings of 229,262 shares indirectly by Riverview Financial Corp. and 5,320 shares indirectly by spouse. The filing notes the plan was established to meet charitable commitments.
FAQ
What is the current stock price of ReposiTrak (TRAK)?
What is the market cap of ReposiTrak (TRAK)?
